Suzan Wopereis | TNO

Dr. Wopereis, principal scientist, joined TNO in 2006 and works with a systems biology research group active on the theme ‘quantification of health and effects of lifestyle on health’, acting as principal investigator in several public private partnerships, as well as on (inter)national research programs focusing on systems health applying genomics technology, bioinformatics, digital biomarkers and standardized infrastructures focusing on systems health. Moreover, she is responsible for scientific contents in the TNO program on personalized health focusing on inflammatory resilience and the TNO program on digital health measurements. In her 16 years of research at TNO, her main focus has been on phenotypic flexibility as a measure of health, where she uses standardized challenge tests to study the response of a multitude of biological processes to quantify resilience in health optimization and remission of chronic lifestyle related diseases such as Diabetes Mellitus type II. On this topic she has >60 peer reviewed scientific publications (https://www.researchgate.net/profile/Suzan_Wopereis/research), with a total H-index of 33. Suzan Wopereis is board member of the Dutch Innovation Center for Lifestyle 4 Health (lifestyle4health.nl/) with the mission to reduce the societal and economic impact of lifestyle related diseases in 10 years. In 2016 she was awarded the ‘Excellent researcher of 2015’ for her work on personalized nutrition. She has a PhD in medical sciences from Radboud University Nijmegen Medical Center (2006).




An initiative of

LEIDEN DRUG DEVELOPMENT CONFERENCE

MORE INFO:
Marije Stofregen
E: lddc@hyphenprojects.nl

Organisational support by:
Congress & Event Services & Hyphen Projects

Registration is closed. 

© Copyright 2022 Leiden Drug Development Conference